Faulkner v. Acella Pharmaceuticals, LLC

Track this case

Case overview

Case Number:

2:22-cv-00092

Court:

Georgia Northern

Nature of Suit:

Racketeer/Corrupt Organization

Multi Party Litigation:

Class Action

Judge:

Richard W. Story

Firms

  1. May 20, 2024

    Ga. Judge OKs $5M Atty Fees In $41M Acella Thyroid Deal

    A Georgia federal judge has signed off on a nearly $41.5 million class action settlement with Acella Pharmaceuticals LLC over faulty thyroid medication, while awarding the class attorneys another $5 million in legal fees courtesy of the pharma company.

  2. May 01, 2024

    Attys Say $5M Fee In Acella Settlement A Modest Proposal

    Plaintiffs' attorneys who recently reached a $46.5 million class action settlement with Acella Pharmaceuticals LLC over faulty thyroid medication asked a Georgia federal judge Tuesday to sign off on their $5 million cut of the deal as a "presumptively reasonable" proposal.

  3. February 07, 2024

    Acella's $46.5M Drug Recall Settlement Gets Initial Signoff

    A Georgia federal judge on Wednesday gave preliminary approval of a nearly $46.5 million settlement from Acella Pharmaceuticals LLC to end a class action alleging the company sold worthless thyroid medication to hundreds of thousands of Americans.

  4. February 05, 2024

    Proposed Class Action Settlement May Cost Acella $46.5M

    A proposed agreement to end a class action over thyroid medication, after a U.S. Food and Drug Administration inspection found products with an active ingredient above and below label specifications, may cost Acella Pharmaceuticals $46.5 million.

  5. July 11, 2023

    Judge Calls Drugmaker's Bid To Strike 'A Bit Disingenuous'

    Acella Pharmaceuticals can't escape a proposed class action over its recalled thyroid medication, a Georgia federal judge ruled, calling some of the company's assertions as to why the plaintiffs could never secure class certification "a bit disingenuous."

  6. May 13, 2022

    Pharmaceutical Co. Sued Over Recalled Thyroid Medication

    Acella Pharmaceuticals is facing down a proposed class action in Georgia federal court over its recalled thyroid medication, which plaintiffs claim was released untested and caused them harm.